Stock Charts
WallstreetSelect
Symbol Lookup

WallStreetSelect 114
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
CELLDEX THERAPEUTICS, Inc. (NQ: CLDX)
12.69 USD  +0.29 (+2.34%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News
Stories about CELLDEX THERAPEUTICS, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
8 Biotech Companies Rethinking Immunotherapy for Brain Tumors
February 22, 2012
As highlighted in our prior articles growing evidence indicates that the field of cancer immunotherapy broadly defined as including passive immunization active immunization and immunostimulation is... Read More
from Minyanville Headlines
Celldex Therapeutics Up 66.4% Since SmarTrend Uptrend Call (CLDX)
February 09, 2012
from Comtex SmarTrend® News Briefs
Traders Get Bullish on Shares of Celldex Therapeutics, Shares Up 6.5% (CLDX)
January 31, 2012
from Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Celldex Therapeutics (CLDX)
January 31, 2012
from Comtex SmarTrend® News Briefs
Traders Get Bullish on Shares of Celldex Therapeutics, Shares Up 5.9% (CLDX)
January 26, 2012
from Comtex SmarTrend® News Briefs
Jefferies Raises Price Target On Celldex Therapeutics (CLDX) 50%
January 24, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7102260 for the full story. Read More
from StreetInsider.com News Articles
Stock to Watch: Celldex Therapeutics Up 6.3% (CLDX)
January 17, 2012
from Comtex SmarTrend® News Briefs
Celldex Therapeutics (CLDX) Begins Phase 1 Clinical Trial of CDX-301
January 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7084596 for the full story. Read More
from StreetInsider.com News Articles
Upgrade Alert for Celldex Therapeutics (CLDX)
January 17, 2012
from Comtex SmarTrend® News Briefs
Roth Capital Upgrades Celldex Therapeutics (CLDX) to Buy
January 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7084353 for the full story. Read More
from StreetInsider.com News Articles
Healthcare investment conferences buzzing with chatter and activity
January 13, 2012
from ACCESSWIRE
Celldex (CLDX) Commences Rindopepimut w/ Avastin Phase 2
January 04, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7052947 for the full story. Read More
from StreetInsider.com News Articles
Jefferies Starts Celldex Therapeutics (CLDX) at Buy
December 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6990625 for the full story. Read More
from StreetInsider.com News Articles
Celldex (CLDX) Launces Rindopepimut Phase 3 in EGFRvIII-Positive Glioblastoma Patients
December 01, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6987088 for the full story. Read More
from StreetInsider.com News Articles
Pre-Open Movers 11/21: (GEDU) (VRUS) (TRH) Higher; (GILD) (JEF) (RIMM) Lower (more...)
November 21, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6966136 for the full story. Read More
from StreetInsider.com News Articles
Celldex (CLDX) Reports Publication of Rindopepimut Phase 2 Data
November 21, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6965615 for the full story. Read More
from StreetInsider.com News Articles
Celldex (CLDX) Initiates CDX-1127 Phase 1 in Certain Malignant Tumors
November 08, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6923652 for the full story. Read More
from StreetInsider.com News Articles
CELLDEX THERAPEUTICS, Inc. (CLDX) Misses Q3 EPS by 1c
November 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6904328 for the full story. Read More
from StreetInsider.com News Articles
Celldex (CLDX) GB Treatment Rindopepimut Gets EMA Orphan Drug Designation
October 31, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6895443 for the full story. Read More
from StreetInsider.com News Articles
Celldex Therapeutics Up 5.8%, Shares Break Through Resistance (CLDX)
October 27, 2011
from Comtex SmarTrend® News Briefs
Celldex Therapeutics Down 14.7% Since SmarTrend Downtrend Call (CLDX)
October 17, 2011
from Comtex SmarTrend® News Briefs
Adjuvants May Hold Key to Unlocking Cancer Immunotherapy Revolution
September 19, 2011
The FDA approval of sipuleucel-T [Provenge®] a patient-specific immunotherapy for androgen independent prostate cancer developed by Dendreon Corporation (DNDN) and ipilimumab [Yervoy®] the first immune... Read More
from Minyanville Headlines
Celldex Therapeutics Down 8.7% Since SmarTrend Downtrend Call (CLDX)
September 12, 2011
from Comtex SmarTrend® News Briefs
Needham & Company Maintains a 'Buy' on Celldex Therapeutics (CLDX); Management Focus Grows on Upcoming Phase 3 Rindopepimut Trial Initiation
August 17, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6724447 for the full story. Read More
from StreetInsider.com News Articles
Celldex Therapeutics (CLDX) Posts Narrower than Expected Q2 Loss of 27c/Sh.
August 03, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6680161 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 08/03: Comcast (CMCSA), Clorox (CLX), Tesla (TSLA), Clearwire (CLWR), ON Semi (ONNN) Report
August 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6679391 for the full story. Read More
from StreetInsider.com News Articles
Celldex (CLDX) Appoints Dr. Ron Pepin as SVP, CBO
July 06, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6621159 for the full story. Read More
from StreetInsider.com News Articles
Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Five Themes Emerged That We Believe Deserve Increased Attention
June 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6598540 for the full story. Read More
from StreetInsider.com News Articles
2 Biotechs to Keep an Eye On
June 21, 2011
There's a new way of treating cancer and these two companies are leading the pack, notes Michael Murphy of New World Investor . Read More
from MoneyShow.com
Unusual 11 Mid-Day Movers 05/18: (NLCI) (SATC) (AERL) Higher; (CWTR) (NOA) (CTRN) Lower
May 18, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6518874 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

©2009 WALL STREET SELECT | Online Media Select, LLC | Privacy Policy | Terms | Advertise | Contact Us